期刊文献+

透明质酸敷料联合吡美莫司乳膏治疗面部敏感性皮肤的疗效观察 被引量:3

下载PDF
导出
摘要 目的探讨透明质酸敷料联合吡美莫司乳膏治疗面部敏感性皮肤的临床疗效及安全性。方法115例面部敏感性皮肤患者,根据治疗方法的不同随机分为三组。观察组,外用1%吡美莫司乳膏,睡前外用透明质酸敷料;对照A组单用1%吡美莫司乳膏;对照B组睡前外用透明质酸敷料。疗程6周。比较治疗前后三组的临床疗效、生活质量和不良发应发生情况。结果治疗6周后,观察组的有效率为76.92%,明显高于对照A组(50.0%)和对照E组(52.63%),差异有统计学意义(P<0.05);观察组的皮肤病生活质量指数分值明显低于对照A组、对照E组,差异有统计学意义(P<0.01)。结论透明质酸敷料与吡美莫司乳膏联合治疗面部敏感性皮肤具有较好的临床疗效,且不良反应少、安全性高。 Objective To investigate the effect and safety of hyaluronic acid gel and pimecroEmus cream on facial sensitive skin.Methods A total of 115 patients with fecial sensitive skin were randomly divided into three groups according to difierent treatment methods.In the observation group,1%pimecrolimus cream was applied externally,and hyaluronic acid dressing was applied before going to bed.The control group A was given 1%pimecrolimus cream alone.The control group B was applied hyaluronic acid dressing before going to bed.The course of treatment was 6 weeks.The clinical efficacy,quality of life,and occurrence of adverse reactions of the three groups before and after treatment were compared.Results After 6 weeks of treatment,the effective rate of the observation group was 76.92%,which was significantly higher than that of the control group A(50.0%)and the control group B(52.63%),the difierence was statistically significant(P<0.05).The skin disease quality of life index score of the observation group was significantly lower than that of the control group A and control group B,and the difierence was statistically significant(P<0.01).Conclusion The combination of hyaluronic acid dressing and pimecrolimus cream for the treatment of sensitive facial skin has a good clinical efiect,with few adverse reactions and high safety.
出处 《浙江临床医学》 2021年第8期1176-1178,共3页 Zhejiang Clinical Medical Journal
关键词 敏感性皮肤 透明质酸 吡美莫司 疗效 Sensitive skin Hyaluronic acid Pimecrolimus Curative effect
  • 相关文献

参考文献7

二级参考文献87

  • 1谢志强,杨高云,姜薇,徐敏丽.吡美莫司乳膏对成年女性面部皮炎快速抗瘙痒机制[J].中国医学科学院学报,2009,31(1):27-30. 被引量:10
  • 2宋慧锋,林子豪,刘宁飞,陈敏亮,朱晓海.人胎儿和成人皮肤及其创面愈合过程中转化生长因子-β的表达[J].中国组织工程研究与临床康复,2001,10(14):60-61. 被引量:6
  • 3Richard D Price,MG Berry,Harshad A Navsaria.Hyaluronic acid:the scientific and clinical evidence.Journal of Plastic[J].Reconstructive & Aesthetic Surgery,2007,60(10):1110-1119.
  • 4Leung DY,Hanifin J,Charlesworth EN,et al.Disease management of atopic dermatitis:a practice parameter[J].Ann Allergy Asthma Immunol,1997,79(9):197-211.
  • 5G Belloni,S Pinelli,S Veraldi.A randomised,double-blind,vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair?) in the treatment of mild to moderate atopic dermatitis[J].European Journal of Dermatology,2005,15(1):31-36.
  • 6Lebwohl M,Herrmann LG.Impaired skin barrier function in dermatologic disease and repair with moisturization[J].Cutis,2005,76(6):7-12.
  • 7Zoe Diana Draelos.An evaluation of prescription device moisturizers[J].Journal of Cosmetic Dermatology,2009,8(1):40-43.
  • 8Wells AF,Lundin A,Micha?lsson G.Histochemical localization of hyaluronan in psoriasis allergic contact dermatitis and normal skin[J].Acta Derm Venereol,1991,71(3):232-238.
  • 9Raija Tammi,James A Ripellino,Richard U Margolis,et al.Localization of epidermal hyaluronic acid using the hyaluronate binding region of cartilage proteoglycan as a specific probe[J].J Invest Dermatol,1988,90(3):412-414.
  • 10Alaish SM,Yager DR,Diegelmann RF,et a1.Hyaluronie acid metab olism in keloid fibmblasts[J].J Pediatr Surg,1995,30(3):942-952.

共引文献177

同被引文献35

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部